|
13 Oct 2010 |
Bavarian Nordic Receives NIH Grant to Investigate the Potential of an MVA-BN(R) Based Vaccine Against Ebola and Marburg Viruses
|
|
13 Oct 2010 |
Medicago and PATH collaborate on broad coverage influenza vaccines for the developing world
|
|
11 Oct 2010 |
BiondVax Begins Phase IIa Study for Universal Flu Vaccine
|
|
07 Oct 2010 |
Synthetic Genomics Inc. and J. Craig Venter Institute Form New Company, Synthetic Genomics Vaccines Inc. (SGVI), to Develop Next Generation Vaccines
|
|
07 Oct 2010 |
Vical to Manufacture DNA Vaccines for Advanced Development by HIV Consortium
|
|
05 Oct 2010 |
Immunovaccine and IRX Therapeutics Collaborate on Cancer Immunotherapies
|
|
05 Oct 2010 |
CureVac presents convincing data from the first ever Phase I/IIa clinical study with a mRNA based vaccine
|
|
05 Oct 2010 |
Liquidia Technologies Initiates Phase 1 Trial of Lead Vaccine Candidate
|
|
04 Oct 2010 |
Dynavax's HEPLISAV Demonstrates Superior Seroprotection in Diabetics Compared to Engerix-B
|
|
04 Oct 2010 |
Celldex Therapeutics Presents Safety and Immunogenicity Data on CDX-1401 at the International Society of Biological Therapy of Cancer Meeting
|
|
30 Sep 2010 |
Circassia Initiates Phase II Trials of Novel Grass and Ragweed Allergy Therapies and Advances Phase III Plans for cat Allergy T-Cell Vaccine
|
|
30 Sep 2010 |
GSK provides update on Herpevac trial for women evaluating Simplirix (Herpes Simplex Vaccine)
|
|
28 Sep 2010 |
Sanofi Pasteur (SASY.PA) Acquires VaxDesign for $60 Million
|
|
28 Sep 2010 |
Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue
|
|
28 Sep 2010 |
Inovio Pharmaceuticals’ HIV DNA Vaccine/Electroporation Delivery Technology Selected for NIH-Sponsored U.S. Army Human Clinical Trial
|
|
24 Sep 2010 |
GSK EU regulatory update on Pandemrix
|
|
23 Sep 2010 |
Dynavax Begins Phase 1b Study for Universal Flu Vaccine
|
|
23 Sep 2010 |
Vaxonco’s EP1300 Epitope-Based DNA Vaccine for Malaria Delivered by Ichor’s TriGrid Electoporation Enters Phase I Trial
|
|
22 Sep 2010 |
Aeras and Crucell Announce Phase II Clinical Trial Start in Kenya
|
|
21 Sep 2010 |
immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
|
|
21 Sep 2010 |
Inovio Completes Enrollment of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation
|
|
17 Sep 2010 |
Immune Network Ltd. (IMMFF) Announces Intent to Acquire Oral Vaccine Technology Platform from Immunitor
|
|
17 Sep 2010 |
CytoGenix, Inc. Initiates Ferret Testing Expecting Positive Results for Avian Flu Vaccine Study
|
|
16 Sep 2010 |
LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
|
|
16 Sep 2010 |
ImmunoCellular Therapeutics Selects Averion International Corp. to Conduct Phase II Glioblastoma Study
|
